These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24383913)

  • 21. Cholesterol promotes the interaction of Alzheimer β-amyloid monomer with lipid bilayer.
    Yu X; Zheng J
    J Mol Biol; 2012 Aug; 421(4-5):561-71. PubMed ID: 22108168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding Amyloid-β Oligomerization at the Molecular Level: The Role of the Fibril Surface.
    Barz B; Strodel B
    Chemistry; 2016 Jun; 22(26):8768-72. PubMed ID: 27135646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alzheimer's amyloid-beta peptide inhibits sodium/calcium exchange measured in rat and human brain plasma membrane vesicles.
    Wu A; Derrico CA; Hatem L; Colvin RA
    Neuroscience; 1997 Oct; 80(3):675-84. PubMed ID: 9276485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fresh and nonfibrillar amyloid beta protein(1-40) induces rapid cellular degeneration in aged human fibroblasts: evidence for AbetaP-channel-mediated cellular toxicity.
    Zhu YJ; Lin H; Lal R
    FASEB J; 2000 Jun; 14(9):1244-54. PubMed ID: 10834946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Cholesterol Molecules on Aβ1-42 Wild-Type and Mutants Trimers.
    Nguyen TH; Nguyen PH; Ngo ST; Derreumaux P
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid β peptides aggregation in a mixed membrane bilayer: a molecular dynamics study.
    Zhao LN; Chiu SW; Benoit J; Chew LY; Mu Y
    J Phys Chem B; 2011 Oct; 115(42):12247-56. PubMed ID: 21910473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene Therapy Strategy for Alzheimer's and Parkinson's Diseases Aimed at Preventing the Formation of Neurotoxic Oligomers in SH-SY5Y Cells.
    El-Battari A; Rodriguez L; Chahinian H; Delézay O; Fantini J; Yahi N; Di Scala C
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induced beta-barrel formation of the Alzheimer's Abeta25-35 oligomers on carbon nanotube surfaces: implication for amyloid fibril inhibition.
    Fu Z; Luo Y; Derreumaux P; Wei G
    Biophys J; 2009 Sep; 97(6):1795-803. PubMed ID: 19751686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism and prevention of neurotoxicity caused by beta-amyloid peptides: relation to Alzheimer's disease.
    Blanchard BJ; Konopka G; Russell M; Ingram VM
    Brain Res; 1997 Nov; 776(1-2):40-50. PubMed ID: 9439794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zn2+ interaction with Alzheimer amyloid beta protein calcium channels.
    Arispe N; Pollard HB; Rojas E
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1710-5. PubMed ID: 8643694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AmyP53 Prevents the Formation of Neurotoxic β-Amyloid Oligomers through an Unprecedent Mechanism of Interaction with Gangliosides: Insights for Alzheimer's Disease Therapy.
    Azzaz F; Chahinian H; Yahi N; Fantini J; Di Scala C
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholesterol Modulates the Formation of the Aβ Ion Channel in Lipid Bilayers.
    Gao Q; Wu G; Lai KWC
    Biochemistry; 2020 Mar; 59(8):992-998. PubMed ID: 31914730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer's disease.
    Cummings JL; Zhong K; Kinney JW; Heaney C; Moll-Tudla J; Joshi A; Pontecorvo M; Devous M; Tang A; Bena J
    Alzheimers Res Ther; 2016 Jan; 8():4. PubMed ID: 26822146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On the physiological/pathological link between Aβ peptide, cholesterol, calcium ions and membrane deformation: A molecular dynamics study.
    Pannuzzo M
    Biochim Biophys Acta; 2016 Jun; 1858(6):1380-9. PubMed ID: 27003127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ion Channel Formation by Amyloid-β42 Oligomers but Not Amyloid-β40 in Cellular Membranes.
    Bode DC; Baker MD; Viles JH
    J Biol Chem; 2017 Jan; 292(4):1404-1413. PubMed ID: 27927987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory Mechanism of An Anticancer Drug, Bexarotene Against Amyloid β Peptide Aggregation: Repurposing Via Neuroinformatics Approach.
    Bibi N; Rizvi SMD; Batool A; Kamal MA
    Curr Pharm Des; 2019; 25(27):2989-2995. PubMed ID: 31368868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effects of bexarotene against amyloid-β25-35-induced dysfunction in hippocampal neurons through the insulin signaling pathway.
    Dai W; Yang J; Chen T; Yang Z
    Neurodegener Dis; 2014; 14(2):77-84. PubMed ID: 24802415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of Cholesterol in Amyloidogenic Substrate Binding to the γ-Secretase Complex.
    Orzeł U; Jakowiecki J; Młynarczyk K; Filipek S
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34202467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-channel Ca(2+) imaging implicates Aβ1-42 amyloid pores in Alzheimer's disease pathology.
    Demuro A; Smith M; Parker I
    J Cell Biol; 2011 Oct; 195(3):515-24. PubMed ID: 22024165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In silico and in vitro studies to elucidate the role of Cu2+ and galanthamine as the limiting step in the amyloid beta (1-42) fibrillation process.
    Hernández-Rodríguez M; Correa-Basurto J; Benitez-Cardoza CG; Resendiz-Albor AA; Rosales-Hernández MC
    Protein Sci; 2013 Oct; 22(10):1320-35. PubMed ID: 23904252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.